← All trials
NCT06022224
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 9, 2020
- Primary completion
- Jun 23, 2022
- Completion date
- Jul 19, 2023
- First posted
- Sep 1, 2023
- Last posted
- Sep 6, 2023
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- ImmunityBio, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.